← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2014Last known activity
Oct 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 8 trials)
Phase 4 (3 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT07200180Lead sponsorPhase 3Oct 1, 2025
- NCT07200180OfficialPhase 3Oct 1, 2025
- NCT07200180Sponsor investigatorPhase 3Oct 1, 2025
- NCT05335109Lead sponsorPhase 3Dec 1, 2022
- NCT05335109Reponsible party - principal investigatorPhase 3Dec 1, 2022
- NCT05335109Sponsor investigatorPhase 3Dec 1, 2022
- NCT05259631Overall official - principal investigatorPhase 3Mar 14, 2022
- NCT05259631Reponsible party - principal investigatorPhase 3Mar 14, 2022
- NCT05259631Lead sponsorPhase 3Mar 14, 2022
- NCT05126238Reponsible party - principal investigatorPhase 3Nov 30, 2021
- NCT05126238Lead sponsorPhase 3Nov 30, 2021
- NCT05126238Overall official - principal investigatorPhase 3Nov 30, 2021
- NCT04800393CollaboratorN/AMar 31, 2021
- NCT04800393Study directorN/AMar 31, 2021
- NCT04453371Lead sponsorPhase 3Oct 15, 2020
Details
- Last known activity
- Oct 1, 2025